Biocon Boosts Biosimilars In Australia With Sandoz Partnership

Five-Year Exclusive Marketing Deal Will Cover Indian Firm’s Trastuzumab And Bevacizumab

 
• By Dave Wallace
  
Australian flag with vial and syringe
Biocon and Sandoz have struck a biosimilars deal in Australia • Source: Shutterstock

More from Deals

More from Business